New Drugs Lift Novartis Profit 12%

July 19, 2011
Sales of recently launched products contributed $3.8 billion to overall group sales, which were up 27% at $14.9 billion.

Swiss pharmaceutical company Novartis said on July 19 that its second quarter net profit rose 12% to $2.72 billion.

"Our recently launched products continue to transform our portfolio, our new products grew 46% and represent now 25% of our group sales in Q2," said Joseph Jimenez, Novartis chief executive officer.

Sales of recently launched products contributed $3.8 billion to overall group sales, which were up 27% at $14.9 billion.

Currency impact lent an 8% boost to overall revenues.

For the rest of the year, the group said it was maintaining its forecast for sales growth reaching "around the double-digit mark.

Copyright Agence France-Presse, 2011

Popular Sponsored Recommendations

Machine Learning and Predictive Analytics Guidebook for Engineers

Sept. 27, 2023
Leverage Domain Expertise to Drive Optimization – Without Needing a Data Scientist.

The Ultimate Ecommerce Excellence Checklist

Oct. 2, 2023
Scaling ecommerce operations is no easy task when your business is moving fast. Assess your current ecommerce maturity level and set optimization priorities with this practical...

State of Sales Report

Sept. 12, 2023
Discover the latest insights driving productivity and efficiency for more than 7,700 sales leaders and professionals.

The Manufacturer's Guide to Modernizing Commercial Operations

Sept. 12, 2023
In this guide, learn how a modern approach to commercial operations can help your manufacturing business integrate sales and revenue management to elevate seller productivity ...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!